Feasibility and safety of avoiding granulocyte colony-stimulating
Study ID
DFCI 15-516
Status
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial
Study ID
DFCI 16-727
Status
Feasibility and safety of avoiding granulocyte colony-stimulating
Study ID
DFCI 15-516